Hypertrophic cardiomyopathy or athlete’s heart? A systematic review of novel cardiovascular magnetic resonance imaging parameters

References

• Androulakis, E., & Swoboda, P. P. (2018). The role of cardiovascular magnetic resonance in sports cardiology; Current utility and future perspectives. Current Treatment Options in Cardiovascular Medicine, 20, 86.
   PubMedGoogle Scholar
• Barczuk-Falęcka, M., Małek, ŁA, Krysztofiak, H., Roik, D., & Brzewski, M. (2018). Cardiac magnetic resonance Assessment of the structural and functional cardiac adaptations to soccer training in school-aged male children. Pediatric Cardiology, 39, 948–954.
   PubMed Web of Science ®Google Scholar
• Bhella, P. S., Hastings, J. L., Fujimoto, N., Shibata, S., Carrick-Ranson, G., Palmer, M. D., et al. (2014). Impact of lifelong exercise “dose” on left ventricular compliance and distensibility. Journal of the American College of Cardiology, 64, 1257–1266.
   PubMed Web of Science ®Google Scholar
• Burrage, M. K., & Ferreira, V. M. (2020). Cardiovascular magnetic resonance for the differentiation of left ventricular hypertrophy. Current Heart Failure Reports, 17, 192–204.
   PubMedGoogle Scholar
• Captur, G., Lopes, L. R., Patel, V., Li, C., Bassett, P., Syrris, P., et al. (2014). Abnormal cardiac formation in hypertrophic cardiomyopathy fractal analysis of trabeculae and preclinical gene expression. Circulation. Cardiovascular Genetics, 7, 241–248.
   PubMedGoogle Scholar
• Cavus, E., Muellerleile, K., Schellert, S., Schneider, J., Tahir, E., Chevalier, C., et al. (2021). CMR feature tracking strain patterns and their association with circulating cardiac biomarkers in patients with hypertrophic cardiomyopathy. Clin Res Cardiol. Springer Berlin Heidelberg, 110(2021), 1757–1769.
   PubMedGoogle Scholar
• Chen, S., Huang, L., Zhang, Q., Wang, J., & Chen, Y. (2020). T2-weighted cardiac magnetic resonance image and myocardial biomarker in hypertrophic cardiomyopathy. Medicine (Baltimore), 99, e20134.
   PubMed Web of Science ®Google Scholar
• Claessen, G., Schnell, F., Bogaert, J., Claeys, M., Pattyn, N., De Buck, F., et al. (2018). Exercise cardiac magnetic resonance to differentiate athlete’s heart from structural heart disease. European Heart Journal Cardiovascular Imaging, 19, 1062–1070.
   PubMed Web of Science ®Google Scholar
• Cross, S. S. (1994). The application of fractal geometric analysis to microscopic images. Micron. England, 25, 101–113.
   PubMed Web of Science ®Google Scholar
• Czimbalmos, C., Csecs, I., Toth, A., Kiss, O., Suhai, F. I., Sydo, N., et al. (2019). The demanding grey zone: Sport indices by cardiac magnetic resonance imaging differentiate hypertrophic cardiomyopathy from athlete’s heart. PLoS One, 14, 1–14.
   Web of Science ®Google Scholar
• Das, A., Chowdhary, A., Kelly, C., Teh, I., Stoeck, C. T., Kozerke, S., et al. (2021). Insight into myocardial microstructure of athletes and hypertrophic Cardiomyopathy Patients using Diffusion tensor imaging. Journal of Magnetic Resonance Imaging, 53, 73–82.
   PubMed Web of Science ®Google Scholar
• Dias, K. A., Link, M. S., & Levine, B. D. (2018). Exercise training for patients With hypertrophic cardiomyopathy: JACC review topic of the week. Journal of the American College of Cardiology United States, 72, 1157–1165.
   PubMedGoogle Scholar
• Eijsvogels, T. M. H., Thompson, P. D., & Franklin, B. A. (2018). The “extreme exercise hypothesis”: recent findings and Cardiovascular health implications. Current Treatment Options in Cardiovascular Medicine, 20(10), 84.
   PubMedGoogle Scholar
• Eijsvogels, T. M. H., Oxborough, D. L., O’Hanlon, R., Sharma, S., Prasad, S., Whyte, G., et al. (2017). Global and regional cardiac function in lifelong endurance athletes with and without myocardial fibrosis. European Journal of Sport Science England, 17, 1297–1303.
   PubMed Web of Science ®Google Scholar
• Galderisi, M., Cardim, N., D’Andrea, A., Bruder, O., Cosyns, B., Davin, L., et al. (2015). The multi-modality cardiac imaging approach to the athlete’s heart: An expert consensus of the European association of Cardiovascular imaging. European Heart Journal: Cardiovascular Imaging England, 16, 353–353r.
   PubMed Web of Science ®Google Scholar
• Gastl, M., Lachmann, V., Christidi, A., Janzarik, N., Veulemans, V., Haberkorn, S., et al. (2020). Cardiac magnetic resonance T2 mapping and feature tracking in athlete’s heart and HCM. Eur radiol. European Radiology, 31(5), 2768–2777.
   PubMed Web of Science ®Google Scholar
• George, K., Whyte, G. P., Green, D. J., Oxborough, D., Shave, R. E., Gaze, D., et al. (2012). The endurance athletes heart: Acute stress and chronic adaptation. British Journal of Sports Medicine England, 46(Suppl 1), i29–i36.
   PubMed Web of Science ®Google Scholar
• Görmeli, C. A., Görmeli, G., Yağmur, J., Özdemir, Z. M., Kahraman, A. S., Çolak, C., et al. (2016). Assessment of myocardial changes in athletes with native T1 mapping and cardiac functional evaluation using 3 T MRI. The International Journal of Cardiovascular Imaging, 32, 975–981.
   PubMed Web of Science ®Google Scholar
• Grigoratos, C., Pantano, A., Meschisi, M., Gaeta, R., Ait-Ali, L., Barison, A., et al. (2020). Clinical importance of late gadolinium enhancement at right ventricular insertion points in otherwise normal hearts. The International Journal of Cardiovascular Imaging, 36, 913–920.
   PubMed Web of Science ®Google Scholar
• Hanson, C. A., Kamath, A., Gottbrecht, M., Ibrahim, S., & Salerno, M. (2020). T2 relaxation times at cardiac MRI in healthy adults: A systematic review and meta-analysis. Radiology, 297, 344–351.
   PubMed Web of Science ®Google Scholar
• Hen, Y., Takara, A., Iguchi, N., Utanohara, Y., Teraoka, K., Takada, K., et al. (2018). High signal intensity on T2-weighted Cardiovascular magnetic resonance imaging predicts life-threatening arrhythmic events in hypertrophic cardiomyopathy patients. Circulation Journal Japan, 82, 1062–1069.
   PubMed Web of Science ®Google Scholar
• Hinojar, R., Fernández-Golfín, C., González-Gómez, A., Rincón, L. M., Plaza-Martin, M., Casas, E., et al. (2017). Prognostic implications of global myocardial mechanics in hypertrophic cardiomyopathy by cardiovascular magnetic resonance feature tracking. Relations to left ventricular hypertrophy and fibrosis. International Journal of Cardiology, 249, 467–472.
   PubMed Web of Science ®Google Scholar
• Hor, K. N., Baumann, R., Pedrizzetti, G., Tonti, G., Gottliebson, W. M., Taylor, M., et al. (2011). Magnetic resonance derived myocardial strain assessment using feature tracking. Journal of Visualized Experiments, 12(48), 2356.
   Google Scholar
• Jaspers, K., Freling, H. G., van Wijk, K., Romijn, E. I., Greuter, M. J. W., & Willems, T. P. (2013). Improving the reproducibility of MR-derived left ventricular volume and function measurements with a semi-automatic threshold-based segmentation algorithm. International Journal of Cardiovascular Imaging. United States, 29, 617–623.
   PubMed Web of Science ®Google Scholar
• Kyriakou, P., Mouselimis, D., Tsarouchas, A., Rigopoulos, A., Bakogiannis, C., Noutsias, M., et al. (2018). Diagnosis of cardiac amyloidosis: A systematic review on the role of imaging and biomarkers. BMC Cardiovasc disord. BMC Cardiovascular Disorders, 18, 1–11.
   PubMed Web of Science ®Google Scholar
• Lepers, R., & Stapley, P. J. (2016). Master athletes Are extending the limits of human endurance. Frontiers in Physiology, 7, 613.
   PubMed Web of Science ®Google Scholar
• Lipton, M. L. (2008). Totally accessible MRI: A User’s guide to principles, technology, and applications. In Robert Albano (Ed.), Total access MRI A User’s guide to principles, technology and applications. (pp. 233–244). New York City, NY, USA: Springer US.
   Google Scholar
• Maestrini, V., Torlasco, C., Hughes, R., & Moon, J. C. (2020). Cardiovascular magnetic resonance and sport cardiology: A growing role in clinical dilemmas. J Cardiovasc Transl Res. Journal of Cardiovascular Translational Research, 13, 296–305.
   PubMed Web of Science ®Google Scholar
• Małek, ŁA, Barczuk-Falęcka, M., Werys, K., Czajkowska, A., Mróz, A., Witek, K., et al. (2019). Cardiovascular magnetic resonance with parametric mapping in long-term ultra-marathon runners. European Journal of Radiology Ireland, 117, 89–94.
   PubMed Web of Science ®Google Scholar
• Małek, ŁA, & Bucciarelli-Ducci, C. (2020). Myocardial fibrosis in athletes-Current perspective. Clinical Cardiology, 43, 882–888.
   PubMed Web of Science ®Google Scholar
• Małek, ŁA, Mazurkiewicz, Ł, Marszałek, M., Barczuk-Falęcka, M., Simon, J. E., Grzybowski, J., et al. (2021). Deformation parameters of the heart in endurance athletes and in patients with dilated cardiomyopathy—A cardiac magnetic resonance study. Diagnostics, 11, 374.
   Web of Science ®Google Scholar
• Malhotra, A., & Sharma, S. (2017). Hypertrophic cardiomyopathy in athletes. European Cardiology Reveiw, 12, 80–82.
   PubMed Web of Science ®Google Scholar
• Mandelbrot, B. (1967). How long is the coast of britain? Statistical self-similarity and fractional dimension. Science (80-), 156, 636–638.
   PubMed Web of Science ®Google Scholar
• Mangion, K., Burke, N. M. M., McComb, C., Carrick, D., Woodward, R., & Berry, C. (2019). Feature-tracking myocardial strain in healthy adults- a magnetic resonance study at 3.0 tesla. Scientific Reports, 9, 3239.
   PubMed Web of Science ®Google Scholar
• Markousis–Mavrogenis, G., Giannakopoulou, A., Andreou, N., Papadopoulos, G., Vartela, V., Kolovou, G., et al. (2020). Cardiovascular magnetic resonance clarifies arrhythmogenicity in asymptomatic young athletes with ventricular arrhythmias undergoing pre–participation evaluation. Experimental and Therapeutic Medicine, 20, 561–571.
   PubMed Web of Science ®Google Scholar
• Maron, B. J., Haas, T. S., Ahluwalia, A., Murphy, C. J., & Garberich, R. F. (2016). Demographics and epidemiology of sudden deaths in young competitive athletes: From the United States National registry. American Journal of Medicine, 129, 1170–1177.
   PubMed Web of Science ®Google Scholar
• Mavrogeni, S. I., Markousis-Mavrogenis, G., Aggeli, C., Tousoulis, D., Kitas, G. D., Kolovou, G., et al. (2019). Arrhythmogenic inflammatory cardiomyopathy in autoimmune rheumatic diseases: A challenge for cardio-rheumatology. Diagnostics, 9(4), 217.
   Web of Science ®Google Scholar
• Mayala, H. A., Bakari, K. H., & Zhaohui, W. (2019). The role of cardiac magnetic resonance (CMR) in the diagnosis of cardiomyopathy: A systematic review. Malawi Medical Journal, 31, 241–245.
   PubMed Web of Science ®Google Scholar
• McDiarmid, A. K., Swoboda, P. P., Erhayiem, B., Lancaster, R. E., Lyall, G. K., Broadbent, D. A., et al. (2016). Athletic cardiac adaptation in males Is a consequence of elevated myocyte mass. Circulation Cardiovascular Imaging, 9, e003579.
   PubMed Web of Science ®Google Scholar
• Mekkaoui, C., Reese, T. G., Jackowski, M. P., Bhat, H., & Sosnovik, D. E. (2017). Diffusion MRI in the heart. NMR in Biomedicine, 30, e3426.
   PubMed Web of Science ®Google Scholar
• Merghani, A., Maestrini, V., Rosmini, S., Cox, A. T., Dhutia, H., Bastiaenan, R., et al. (2017). Prevalence of subclinical coronary artery disease in masters endurance athletes With a Low atherosclerotic risk profile. Circulation, 136, 126–137.
   PubMed Web of Science ®Google Scholar
• Meyers, S. M., Kolind, S. H., Laule, C., & MacKay, A. L. (2016). Measuring water content using T2 relaxation at 3T: Phantom validations and simulations. Magnetic Resonance Imaging Netherlands, 34, 246–251.
   PubMed Web of Science ®Google Scholar
• Mitchell, A. R. J., MacLachlan, H. I., & Le Page, P. (2013). Deconditioning the athletic heart. Bmj Case Reports, 2013, 1–2.
   Google Scholar
• Pelliccia, A., Maron, B. J., De Luca, R., Di Paolo, F. M., Spataro, A., & Culasso, F. (2002). Remodeling of left ventricular hypertrophy in elite athletes after long-term deconditioning. Circulation, 105, 944–949.
   PubMed Web of Science ®Google Scholar
• Petersen, S. E., Selvanayagam, J. B., Francis, J. M., Myerson, S. G., Wiesmann, F., Robson, M. D., et al. (2005). Differentiation of athlete’s heart from pathological forms of cardiac hypertrophy by means of geometric indices derived from cardiovascular magnetic resonance. Journal of Cardiovascular Magnetic Resonance, 7, 551–558.
   PubMed Web of Science ®Google Scholar
• Scatteia, A., Baritussio, A., & Bucciarelli-Ducci, C. (2017). Strain imaging using cardiac magnetic resonance. Heart Fail Rev. Heart Failure Reviews, 22, 465–476.
   PubMed Web of Science ®Google Scholar
• Sheikh, N., Papadakis, M., Schnell, F., Panoulas, V., Malhotra, A., Wilson, M., et al. (2015). Clinical profile of athletes with hypertrophic cardiomyopathy. Circulation Cardiovascular Imaging, 8, 1–9.
   Web of Science ®Google Scholar
• Starekova, J., Thottakara, T., Lund, G. K., Welsch, G. H., Brunner, F. J., Muellerleile, K., et al. (2020). Increased myocardial mass and attenuation of myocardial strain in professional male soccer players and competitive male triathletes. The International Journal of Cardiovascular Imaging, 36, 2187–2197.
   PubMed Web of Science ®Google Scholar
• Swoboda, P. P., Erhayiem, B., McDiarmid, A. K., Lancaster, R. E., Lyall, G. K., Dobson, L. E., et al. (2016a). Relationship between cardiac deformation parameters measured by cardiovascular magnetic resonance and aerobic fitness in endurance athletes. J Cardiovasc Magn reson. Journal of Cardiovascular Magnetic Resonance, 18, 1–8.
   PubMed Web of Science ®Google Scholar
• Swoboda, P. P., McDiarmid, A. K., Erhayiem, B., Broadbent, D. A., Dobson, L. E., Garg, P., et al. (2016b). Assessing myocardial extracellular volume by T1 mapping to distinguish hypertrophic cardiomyopathy from athlete’s heart. Journal of the American College of Cardiology, 67, 2189–2190.
   PubMed Web of Science ®Google Scholar
• Swoboda, P. P., McDiarmid, A. K., Erhayiem, B., Law, G. R., Garg, P., Broadbent, D. A., et al. (2017). Effect of cellular and extracellular pathology assessed by T1 mapping on regional contractile function in hypertrophic cardiomyopathy. Journal of Cardiovascular Magnetic Resonance, 19, 16.
   PubMed Web of Science ®Google Scholar
• Taylor, A. J., Salerno, M., Dharmakumar, R., & Jerosch-Herold, M. (2016). T1 mapping: Basic techniques and clinical applications. JACC Cardiovasc Imaging United States, 9, 67–81.
   PubMed Web of Science ®Google Scholar
• Tower-Rader, A., Mohananey, D., To, A., Lever, H. M., Popovic, Z. B., & Desai, M. Y. (2019). Prognostic value of global longitudinal strain in hypertrophic cardiomyopathy: A systematic review of existing literature. JACC Cardiovasc Imaging United States, 12, 1930–1942.
   PubMed Web of Science ®Google Scholar
• Vilades, D., Garcia-Moll, X., Gomez-Llorente, M., Pujadas, S., Ferrero-Gregori, A., Doñate, T., et al. (2021). Differentiation of athlete’s heart and hypertrophic cardiomyopathy by the fractal dimension of left ventricular trabeculae. International Journal of Cardiology, 330, 232–237.
   PubMed Web of Science ®Google Scholar
• Whiting, P. F. (2011). QUADAS-2: A revised tool for the Quality Assessment of Diagnostic Accuracy studies. Annals of Internal Medicine, 155, 529.
   PubMed Web of Science ®Google Scholar
• Winkelmann, Z. K., & Crossway, A. K. (2017). Optimal Screening methods to detect cardiac Disorders in athletes: An evidence-based review. Journal of Athletic Training, 52, 1168–1170.
   PubMed Web of Science ®Google Scholar
• Xu, J., Zhuang, B., Sirajuddin, A., Li, S., Huang, J., Yin, G., et al. (2020). MRI t1 mapping in hypertrophic cardiomyopathy: Evaluation in patients without late gadolinium enhancement and hemodynamic obstruction. Radiology, 294, 275–286.
   PubMed Web of Science ®Google Scholar